The antidepressant-like pharmacological profile of Yuanzhi-1, a novel serotonin, norepinephrine and dopamine reuptake inhibitor

Antai-Otong, 2004, Bipolar II or unipolar depression: pharmacologic considerations, Perspect. Psychiatr. Care, 40, 125, 10.1111/j.1744-6163.2004.tb00008.x Artaiz, 2005, Preclinical pharmacology of F-98214-TA, a novel potent serotonin and norepinephrine uptake inhibitor with antidepressant and anxiolytic properties, Psychopharmacology, 182, 400, 10.1007/s00213-005-0087-3 Belmaker, 2008, The future of depression psychopharmacology, CNS Spectr., 13, 682, 10.1017/S1092852900013766 Bodenlos, 2007, Vagus nerve stimulation acutely alters food craving in adults with depression, Appetite, 48, 145, 10.1016/j.appet.2006.07.080 Bodnoff, 1988, The effects of chronic antidepressant treatment in an animal model of anxiety, Psychopharmacology, 95, 298, 10.1007/BF00181937 Bondi, 2008, Chronic unpredictable stress induces a cognitive deficit and anxiety-like behavior in rats that is prevented by chronic antidepressant drug treatment, Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol., 33, 320, 10.1038/sj.npp.1301410 Bourin, 1990, Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?, Fundam. Clin. Pharmacol., 4, 49, 10.1111/j.1472-8206.1990.tb01016.x Brenes, 2009, The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum, Behav. Brain Res., 198, 199, 10.1016/j.bbr.2008.10.036 Bymaster, 2001, Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors, Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol., 25, 871, 10.1016/S0893-133X(01)00298-6 Carboni, 1989, Serotonin release estimated by transcortical dialysis in freely-moving rats, Neuroscience, 32, 637, 10.1016/0306-4522(89)90285-6 Chen, 2013, Antidepressant-like activity of YL-0919: a novel combined selective serotonin reuptake inhibitor and 5-HT1A receptor agonist, PloS One, 8, e83271, 10.1371/journal.pone.0083271 Cryan, 2002, Noradrenergic lesions differentially alter the antidepressant-like effects of reboxetine in a modified forced swim test, Eur. J. Pharmacol., 436, 197, 10.1016/S0014-2999(01)01628-4 De Pablo, 1989, Learned immobility explains the behavior of rats in the forced swimming test, Physiol. Behav., 46, 229, 10.1016/0031-9384(89)90261-8 Duncan, 1985, Rapid down regulation of beta adrenergic receptors by combining antidepressant drugs with forced swim: a model of antidepressant-induced neural adaptation, J. Pharmacol. Exp. Ther., 234, 402 Dutta, 2013, A low-cost point-of-care testing system for psychomotor symptoms of depression affecting standing balance: a preliminary study in India, Depress. Res. Treat., 2013, 640861 Forbes, 1996, Chronic mild stress and sucrose consumption: validity as a model of depression, Physiol. Behav., 60, 1481, 10.1016/S0031-9384(96)00305-8 Janowsky, 1986, Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex, J. Neurochem., 46, 1272, 10.1111/j.1471-4159.1986.tb00649.x Jin, 2014, The discovery of Yuanzhi-1, a triterpenoid saponin derived from the traditional Chinese medicine, has antidepressant-like activity, Prog. Neuro-Psychopharmacol. Biol. Psychiatry, 53, 9, 10.1016/j.pnpbp.2014.02.013 Jin, 2012, The extracts of Fructus Akebiae, a preparation containing 90% of the active ingredient hederagenin: serotonin, norepinephrine and dopamine reuptake inhibitor, Pharmacol., Biochem., Behav., 100, 431, 10.1016/j.pbb.2011.10.001 Licinio, 2011, Advances in depression research: 2011, Mol. Psychiatry, 16, 686, 10.1038/mp.2011.74 Matthews, 2005, Animal models of depression: navigating through the clinical fog, Neurosci. Biobehav. Rev., 29, 503, 10.1016/j.neubiorev.2005.03.005 Millan, 2001, S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine, J. Pharmacol. Exp. Ther., 298, 565 Mineur, 2006, Effects of unpredictable chronic mild stress on anxiety and depression-like behavior in mice, Behav. Brain Res., 175, 43, 10.1016/j.bbr.2006.07.029 Mischoulon, 2000, Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians, Can. J. Psychiatry. Rev. Can. de Psychiatr., 45, 476, 10.1177/070674370004500509 Murone, 1997, Distribution of bradykinin B2 receptors in sheep brain and spinal cord visualized by in vitro autoradiography, J. Comp. Neurol., 381, 203, 10.1002/(SICI)1096-9861(19970505)381:2<203::AID-CNE7>3.0.CO;2-7 Nutt, 2006, Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment, J. Clin. Psychiatry, 67, 46 Papp, 1996, Pharmacological validation of the chronic mild stress model of depression, Eur. J. Pharmacol., 296, 129, 10.1016/0014-2999(95)00697-4 Parker, 2005, Beyond major depression, Psychol. Med., 35, 467, 10.1017/S0033291704004210 Porsolt, 1977, Behavioural despair in mice: a primary screening test for antidepressants, Arch. Int. de Pharmacodyn. et de Ther., 229, 327 Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0 Silk, 2007, Resilience among children and adolescents at risk for depression: mediation and moderation across social and neurobiological contexts, Dev. Psychopathol., 19, 841, 10.1017/S0954579407000417 Steru, 1985, The tail suspension test: a new method for screening antidepressants in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Trivedi, 2008, Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression, J. Clin. Psychiatry, 69, 246, 10.4088/JCP.v69n0211 Willner, 1984, The validity of animal models of depression, Psychopharmacology, 83, 1, 10.1007/BF00427414 Willner, 2005, Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS, Neuropsychobiology, 52, 90, 10.1159/000087097 Willner, 1987, Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant, Psychopharmacology, 93, 358, 10.1007/BF00187257 Xue, 2013, Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor, Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol., 23, 728, 10.1016/j.euroneuro.2012.06.001